FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297547897> ?p ?o ?g. }

• W4297547897 endingPage "2046" @default.
• W4297547897 startingPage "2046" @default.
• W4297547897 abstract "A significant number of patients with severe cardiovascular disease, undergoing coronary artery bypass grafting (CABG), present with hypertension. While internal mammary arteries (IMAs) may be a better alternative to vein grafts, their impaired vasodilator function affects their patency. Our objectives were to (1) determine if inhibition of the cytochrome P450 enzyme CYP1B1, using liposome-encapsulated 2,3′,4,5′-tetramethoxystilbene (TMS), can potentiate vasodilation of IMAs from CABG patients, and (2) assess mechanisms involved using coronary arteries from normal rats, in an ex vivo model of hypertension. PEGylated liposomes were synthesized and loaded with TMS (mean diameter 141 ± 0.9 nm). Liposomal delivery of TMS improved its bioavailability Compared to TMS solution (0.129 ± 0.02 ng/mL vs. 0.086 ± 0.01 ng/mL at 4 h; p < 0.05). TMS-loaded liposomes alleviated attenuated endothelial-dependent acetylcholine (ACh)-induced dilation in diseased IMAs (@ACh 10−4 M: 56.9 ± 5.1%; n = 8 vs. 12.7 ± 7.8%; n = 6; p < 0.01) for TMS-loaded liposomes vs. blank liposomes, respectively. The alleviation in dilation may be due to the potent inhibition of CYP1B1 by TMS, and subsequent reduction in reactive oxygen species (ROS) moieties and stimulation of nitric oxide synthesis. In isolated rat coronary arteries exposed to a hypertensive environment, TMS-loaded liposomes potentiated nitric oxide and endothelium-derived hyperpolarization pathways via AMPK. Our findings are promising for the future development of TMS-loaded liposomes as a promising therapeutic strategy to enhance TMS bioavailability and potentiate vasodilator function in hypertension, with relevance for early and long-term treatment of CABG patients, via the sustained and localized TMS release within IMAs." @default.
• W4297547897 created "2022-09-29" @default.
• W4297547897 creator A5003832179 @default.
• W4297547897 creator A5021918263 @default.
• W4297547897 creator A5042024511 @default.
• W4297547897 creator A5042558607 @default.
• W4297547897 creator A5044404318 @default.
• W4297547897 creator A5055770362 @default.
• W4297547897 creator A5069786778 @default.
• W4297547897 creator A5073340167 @default.
• W4297547897 creator A5075825805 @default.
• W4297547897 creator A5077757215 @default.
• W4297547897 creator A5085543468 @default.
• W4297547897 date "2022-09-26" @default.
• W4297547897 modified "2023-10-14" @default.
• W4297547897 title "Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene" @default.
• W4297547897 cites W1522760684 @default.
• W4297547897 cites W1538863270 @default.
• W4297547897 cites W1993760969 @default.
• W4297547897 cites W2004609916 @default.
• W4297547897 cites W2015022497 @default.
• W4297547897 cites W2021367421 @default.
• W4297547897 cites W2041719399 @default.
• W4297547897 cites W2055836748 @default.
• W4297547897 cites W2060930105 @default.
• W4297547897 cites W2074146656 @default.
• W4297547897 cites W2078575160 @default.
• W4297547897 cites W2086884504 @default.
• W4297547897 cites W2088991084 @default.
• W4297547897 cites W2113401372 @default.
• W4297547897 cites W2116763228 @default.
• W4297547897 cites W2122067835 @default.
• W4297547897 cites W2135814736 @default.
• W4297547897 cites W2140082905 @default.
• W4297547897 cites W2145474242 @default.
• W4297547897 cites W2147537724 @default.
• W4297547897 cites W2149686234 @default.
• W4297547897 cites W2164480418 @default.
• W4297547897 cites W2169143571 @default.
• W4297547897 cites W2325456168 @default.
• W4297547897 cites W2345376584 @default.
• W4297547897 cites W2346489100 @default.
• W4297547897 cites W2410298734 @default.
• W4297547897 cites W2413954571 @default.
• W4297547897 cites W2617060383 @default.
• W4297547897 cites W2656203895 @default.
• W4297547897 cites W2765762940 @default.
• W4297547897 cites W2792306739 @default.
• W4297547897 cites W2885816098 @default.
• W4297547897 cites W2896641891 @default.
• W4297547897 cites W2898415565 @default.
• W4297547897 cites W2909981430 @default.
• W4297547897 cites W2989866374 @default.
• W4297547897 cites W2994666424 @default.
• W4297547897 cites W3016296237 @default.
• W4297547897 cites W3016861850 @default.
• W4297547897 cites W3037229701 @default.
• W4297547897 cites W3037599047 @default.
• W4297547897 cites W3044076711 @default.
• W4297547897 cites W3108699983 @default.
• W4297547897 cites W3123340144 @default.
• W4297547897 cites W3131959984 @default.
• W4297547897 cites W3144352813 @default.
• W4297547897 cites W3151260118 @default.
• W4297547897 cites W4200147111 @default.
• W4297547897 doi "https://doi.org/10.3390/pharmaceutics14102046" @default.
• W4297547897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36297480" @default.
• W4297547897 hasPublicationYear "2022" @default.
• W4297547897 type Work @default.
• W4297547897 citedByCount "1" @default.
• W4297547897 countsByYear W42975478972023 @default.
• W4297547897 crossrefType "journal-article" @default.
• W4297547897 hasAuthorship W4297547897A5003832179 @default.
• W4297547897 hasAuthorship W4297547897A5021918263 @default.
• W4297547897 hasAuthorship W4297547897A5042024511 @default.
• W4297547897 hasAuthorship W4297547897A5042558607 @default.
• W4297547897 hasAuthorship W4297547897A5044404318 @default.
• W4297547897 hasAuthorship W4297547897A5055770362 @default.
• W4297547897 hasAuthorship W4297547897A5069786778 @default.
• W4297547897 hasAuthorship W4297547897A5073340167 @default.
• W4297547897 hasAuthorship W4297547897A5075825805 @default.
• W4297547897 hasAuthorship W4297547897A5077757215 @default.
• W4297547897 hasAuthorship W4297547897A5085543468 @default.
• W4297547897 hasBestOaLocation W42975478971 @default.
• W4297547897 hasConcept C120770815 @default.
• W4297547897 hasConcept C126322002 @default.
• W4297547897 hasConcept C181389837 @default.
• W4297547897 hasConcept C185154212 @default.
• W4297547897 hasConcept C185592680 @default.
• W4297547897 hasConcept C202751555 @default.
• W4297547897 hasConcept C26291073 @default.
• W4297547897 hasConcept C2780972559 @default.
• W4297547897 hasConcept C519581460 @default.
• W4297547897 hasConcept C55493867 @default.
• W4297547897 hasConcept C71924100 @default.
• W4297547897 hasConcept C98274493 @default.
• W4297547897 hasConceptScore W4297547897C120770815 @default.
• W4297547897 hasConceptScore W4297547897C126322002 @default.

• next